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It is with great pleasure that I introduce to you the new editorial
team that will be leading the Journal of Hepatology for the next
ﬁve years. The Journal of Hepatology is the ofﬁcial journal of
the European Association for the Study of the Liver (EASL), the
premier liver association in Europe. It is a true privilege and hon-
our to have been chosen by the EASL Governing Board as the new
Editor-In-Chief of the Journal of Hepatology. Since its founding in
1985, the journal has seen an impressive development and read-
ership numbers are continually increasing, with a worldwide dis-
tribution now reaching more than 20,000 readers. Under the
direction of the previous Editors, the impact factor of the Journal
steadily increased to 7.056 and now ranks second amongst jour-
nals dedicated to Hepatology, and fourth amongst journals in the
ﬁeld of Hepatogastroenterology. Over the past few years, EASL
has become renown as a leading international Society devoted
to hepatology. The last EASL annual congress, called the Interna-
tional Liver CongressTM, welcomed more than 7000 attendees and
has propelled EASL to the forefront of international hepatology.
We expect that the Journal of Hepatology will follow this fantas-
tic development and become the reference in the ﬁeld. To achieve
this goal, a new editorial team has been assembled that includes
one Editor-In-Chief, two Co-Editors, sixteen Associate Editors,
seven special section Editors, and a statistical consultant. The
new editorial team will have the formidable task of selecting
the best papers, highlighting the most recent advances in hepa-
tology, all with the ultimate aim of increasing readership, distri-
bution, and impact factor of the journal.
Several important changes will take place with the new edito-
rial team. In order to closely represent the international aspect of
our society, the core editorial team will also have member repre-
sentatives from outside Europe. Our two Co-Editors, Peter Galle
and Christopher Day are from Germany and the United Kingdom,
respectively; while members of our Associate Editors team come
from Europe, North America, and Asia. Likewise the Editorial
Board is fully international. A new development for the journal
is the establishment of a Central Editorial Ofﬁce located at the
EASL headquarters in Geneva, Switzerland, which will be man-
aged by Sonia Guimil and Adam Swetloff, Editorial Manager
and Editorial Assistant, respectively. All manuscript submissions
and management will be occurring through a new system calledJournal of Hepatology 20
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With this new team, you will ﬁnd that the layout of the Jour-
nal has changed. Most noticeably, the graphic designers have cre-
ated a new cover which also includes the new trademarked EASL
logo. Some of the previously published Special Sections will con-
tinue in the new version of the journal but under new names.
However, several new sections will appear within the next
months. The Journal will introduce a Focus section, directed by
Daniel Shouval, which will highlight the most poignant manu-
scripts in each issue. A new section entitled Hepatology Snapshot,
led by Massimo Levrero, will brieﬂy aim to describe either a basic
mechanism of a molecular pathway, a detailed application of a
new drug, or a schematic representation of a clinical aspect in
hepatology. The Clinical Application of Basic Science section
under the direction of David Adams will provide the reader with
further insights into basic science within and outside the ﬁeld of
hepatology which have potential clinical application for hepatol-
ogists. This section will be an extraordinary opportunity to
broaden and diversify the scientiﬁc horizons of the Journal. The
section Frontiers in Liver Transplantation will provide insight into
the most recent breakthrough in the ﬁeld of liver transplantation.
In this section, Marina Berenguer will continue previous efforts
by Pierre Clavien to emphasize that liver transplantation is now
considered a permanent trend within the ﬁeld of hepatology.
Under the direction of Graeme Alexander, highly debated issues
will be highlighted in Controversies in Hepatology. This section
will not simply summarize the pros and cons of speciﬁc issues,
but will present the controversial advice of two experts with dif-
fering opinion on a current clinical and basic subject. We hope
that this section will open up these subjects to scientiﬁc debate.
Lastly, Patrick Marcellin, Josep Llovet, and Detlef Schuppan will
keep you updated with the most relevant papers published in
other journals in the International Hepatology section. The Edito-
rial team will be open to comments from our readers and any
suggestions that can improve the quality of the journal will be
greatly welcomed.
My personal expertise which I will bring to the Journal of
Hepatology is from the ﬁeld of liver transplantation. I have
worked on the mechanisms and therapeutic aspects of the recur-
rence of hepatitis B and C after post-transplantation and also on
many clinical and therapeutic aspects of liver failure; however,
my interest in hepatology extends well beyond these specialized
ﬁelds. As both head of a Liver unit and Liver ICU and director of an
Inserm Research unit, over the years I have become absolutely
convinced of the importance of the interface between basic sci-10 vol. 52 j 5–6
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ence and clinical applications. Indeed, Hepatology has been going
through extraordinary changes over the last thirty years. The ﬁeld
has been revolutionized by the emergence of liver transplanta-
tion which dramatically modiﬁed the prognosis of the most
severe patients; also rapid progress has been made in the patho-
physiologic comprehension of the mechanisms of liver diseases
leading to a formidable therapeutic jump in the ﬁelds of portal
hypertension, severe cirrhosis, viral hepatitis, and more recently
in hepatocellular carcinoma. The aim of the Journal of Hepatology
will therefore be to keep the reader at the forefront of all break-
through developments in the ﬁelds of liver cancer, biliary cancer,
viral hepatitis, portal hypertension, liver failure, liver injury, non-
alcoholic fatty liver disease, alcoholic liver disease, cholestasis,
metabolic disease, autoimmune liver diseases, liver transplanta-
tion, aswell as genetic andproteomic developments inhepatology.
I am conﬁdent that the upcoming years will bring numerous
advances in the ﬁelds of liver regeneration, treatment of liver fail-
ure, and liver support.
Before concluding, I have several people to thank. I wish to
personally thank Professor Jean-Pierre Benhamou, who unfortu-
nately passed away in 2008. He was my mentor in hepatology,
an extraordinary teacher, and a gentleman with very high scien-
tiﬁc ambitions. He was also a former Editor of the Journal of
Hepatology and I hope to continue the high scientiﬁc and edito-
rial standard of his work. I wish to thank Professor Henri Bis-
muth, an exceptional liver surgeon who ﬁrst understood the
importance of the interplay between surgery and medicine in
Hepatology, and who granted me trust. I also would like to
thank Professor Christian Brechot, with whom scientiﬁc collabo-
rations are always a fantastic booster. I thank Professor Daniel6 Journal of Hepatology 2Shouval for his continuous friendship. I would like to thank
the team of physicians and surgeons who have worked with
me at Hospital Paul Brousse over the years. I thank all the past
Editors of the Journal for their extraordinary work and in partic-
ular Juan Rodés who gave me the opportunity to work with him
as an Associate Editor. I would like to send a personal thank you
to Professor Massimo Colombo and his team who have brought
the Journal to its highest impact factor yet, have maintained
high standards, and have greatly helped to ensure a smooth
and fruitful transition to the new Editorial team. I thank Jordi
Bruix, Massimo Levrero, Detlef Schuppan, and Andy Burroughs,
all past EASL secretaries, for the work done together when I
was a member of the EASL scientiﬁc committee and for their
continuous support. I thank the former and current EASL
Secretary Generals, Jean-Michel Pawlotsky and Heiner Wede-
meyer, respectively, and the EASL Governing Board for their
trust in me for choosing our team to lead the journal. I wish
to thank Professor Christopher Day and Professor Peter Galle
who accepted to participate in the frontline of this adventure.
I also thank Richard Moreau, Pierre Bedossa, and Thomas Baum-
ert for their input in the conceptualization of the Journal. I thank
the entire team of Associate Editors and Special Section editors
who accepted to be part of the new team and who will face
the task of further improving the quality and impact of the
Journal.
In the upcoming years, we face the formidable yet exciting
challenge to bolster the already reputable scientiﬁc level of the
Journal but also to bring it to new heights of excellence. Only
by doing so, we will be representing EASL at its best.010 vol. 52 j 5–6
